Blog 2: Doctor-Focused Clinical Version: Pituitary Tumors: A Clinical Guide for Eye Doctors

Pituitary tumors are common sellar masses that eye doctors may detect through visual field loss, optic neuropathy, cranial nerve findings, or unexplained neuro-ophthalmic symptoms. Most are benign pituitary adenomas, but their location near the optic chiasm makes them clinically important for optometrists and ophthalmologists.

The American Cancer Society reports that more than 15,000 pituitary tumors are diagnosed each year in the United States, with the majority being benign adenomas rather than carcinomas.

Doctor explains pituitary tumor findings to a patient during an eye exam in a clinic, with vision chart and a bitemporal visual field

How Common Are Pituitary Tumors?

Pituitary adenomas are among the most common intracranial tumors. Epidemiologic studies estimate clinically recognized pituitary adenoma prevalence around 76 to 116 cases per 100,000 people, with incidence estimates around 3.9 to 7.4 cases per 100,000 per year.

However, incidental pituitary lesions are much more common than clinically diagnosed disease. The Endocrine Society guideline notes that combined autopsy data found an average pituitary adenoma frequency of 10.6%. A systematic review estimated an overall pituitary adenoma prevalence of 16.7% when combining autopsy and radiologic studies.

Clinically, the distinction is important: many microadenomas are incidental and asymptomatic, while macroadenomas are more likely to cause compressive visual pathway disease.

Classification

Pituitary tumors may be described by size:

Microadenoma: less than 10 mmMacroadenoma: 10 mm or largerGiant adenoma: often described as greater than 40 mm

They may also be classified as:

Functioning tumors: secrete hormonesNonfunctioning tumors: do not produce clinically significant hormone excess

Common functioning adenomas include:

• Prolactinomas

• Growth hormone-secreting adenomas

• ACTH-secreting adenomas

• TSH-secreting adenomas, less common

Prolactin-secreting adenomas are commonly cited as the most frequent functioning pituitary adenoma. Johns Hopkins notes that prolactin-secreting adenomas account for approximately 30% of all pituitary tumors.

Why Pituitary Tumors Matter in Eye Care

The pituitary gland lies inferior to the optic chiasm. Superior extension of a macroadenoma can compress the crossing nasal retinal fibers, producing the classic:

Bitemporal Hemianopia

This is the classic visual field defect associated with pituitary chiasmal compression.

The earliest defects may be subtle and asymmetric. Clinicians may see:

• Superior temporal defects

• Bitemporal depression

• Junctional scotoma if anterior chiasmal involvement

• Generalized depression in advanced cases

• Optic disc pallor in chronic compression

• Reduced retinal nerve fiber layer and ganglion cell complex on OCT

A normal fundus exam does not rule out a compressive lesion. Visual field testing is often the key diagnostic clue.

Clinical Symptoms That Should Raise Suspicion

Patients may present with:

• Headaches

• Peripheral vision loss

• Difficulty driving

• Bumping into objects

• Reading difficulty

• Diplopia

• Ptosis

• Decreased acuity in advanced cases

• Optic nerve pallor

• Unexplained visual field defects respecting the vertical midline

Hormonal symptoms may include:

• Galactorrhea

• Amenorrhea

• Infertility

• Erectile dysfunction

• Low libido

• Acromegalic facial, hand, or foot changes

• Weight gain, bruising, or Cushingoid features

• Fatigue or signs of hypopituitarism

• 
  

Eye Exam Findings

A clinical eye exam should include:

1. Visual Acuity

Acuity may remain normal early, especially if compression affects the chiasm before the optic nerves.

2. Pupils

Look for RAPD if asymmetric optic nerve involvement is present.

3. Extraocular Motility

Large tumors or cavernous sinus extension may affect cranial nerves III, IV, V1, V2, or VI.

Possible findings include:

• Diplopia

• Partial third nerve palsy

• Sixth nerve palsy

• Ptosis

• Anisocoria if parasympathetic fibers are involved

4. Confrontation Fields

May reveal temporal field loss, but automated perimetry is far more sensitive.

5. Automated Visual Fields

Humphrey 30-2 or 24-2 can identify chiasmal patterns. A 30-2 may be preferred when evaluating broader neurologic defects.

Look for:

• Bitemporal hemianopia

• Temporal depression respecting the vertical midline

• Superior temporal defects

• Asymmetric chiasmal loss

• Poor reliability that still repeatedly shows neurologic pattern

6. Dilated Fundus Exam

Assess for:

• Optic nerve pallor

• Cup-to-disc asymmetry

• RNFL loss

• Other retinal causes of field loss

7. OCT RNFL and Ganglion Cell Analysis

OCT may show:

• Temporal RNFL thinning

• Nasal macular ganglion cell loss

• Chiasmal compression patterns

• Chronic optic atrophy

Ganglion cell complex loss can be particularly useful in compressive optic neuropathy.

Clinical Pearl: Respect the Vertical Midline

Glaucoma typically respects the horizontal raphe. Neurologic visual field defects often respect the vertical midline.

A visual field defect that respects the vertical midline should trigger consideration of a retrobulbar, chiasmal, or post-chiasmal lesion.

Differential Diagnosis for Bitemporal or Chiasmal-Like Field Loss

Consider:

• Pituitary macroadenoma

• Meningioma

• Craniopharyngioma

• Aneurysm

• Optic chiasm glioma

• Metastatic lesion

• Inflammatory or infiltrative disease

• Tilted discs or high myopia mimicking temporal defects

• Poor test reliability/artifact

Repeatable, neurologic-pattern visual field loss deserves further workup.

When to Refer for Imaging

Refer urgently or order neuroimaging when the patient has:

• Repeatable bitemporal visual field loss

• Visual field defects respecting the vertical midline

• Optic nerve pallor inconsistent with glaucoma

• Unexplained reduced vision with neurologic field loss

• Cranial nerve palsy

• New diplopia with headache

• Progressive peripheral vision loss

• Symptoms suggestive of pituitary apoplexy

MRI of the brain and orbits with attention to the sella/pituitary, with and without contrast, is typically the preferred imaging study.

Pituitary Apoplexy: Do Not Miss This

Pituitary apoplexy is an emergency caused by hemorrhage or infarction within the pituitary gland, often within an adenoma.

Symptoms may include:

• Sudden severe headache

• Acute vision loss

• Ophthalmoplegia

• Ptosis

• Nausea and vomiting

• Altered mental status

• Adrenal insufficiency

This requires emergency evaluation.

Management Overview

Treatment depends on tumor type, size, symptoms, hormone activity, and compression.

Management may involve:

• Endocrinology evaluation

• Hormonal bloodwork

• MRI monitoring

• Dopamine agonist therapy for many prolactinomas

• Transsphenoidal surgery for compressive or certain functioning tumors

• Radiation in select recurrent or residual cases

• Serial visual fields and OCT monitoring

Eye doctors play an important role in documenting baseline visual function and monitoring recovery or progression after treatment.

Follow-Up Role for Optometry and Ophthalmology

After diagnosis or treatment, eye care follow-up may include:

• Visual acuity

• Pupils

• Color vision

• Optic nerve evaluation

• OCT RNFL/GCC

• Serial automated visual fields

• Diplopia assessment

• Documentation of optic atrophy or recovery

Visual field improvement may occur after decompression, but chronic compression can leave permanent optic nerve damage.

Key Clinical Takeaway

Pituitary tumors are common, usually benign, and often asymptomatic when small. For eye doctors, the critical issue is recognizing when a pituitary lesion is affecting the visual pathway. A repeatable bitemporal field defect, visual field loss respecting the vertical midline, unexplained optic pallor, or neurologic symptoms should prompt neuroimaging and referral.